News Details

Hamad Medical Corporation (HMC) has recently hosted the eighth Qatar Annual Breast Cancer Conference, bringing together first-class local and international speakers, comprising over 300 participants from Qatar, the region, and abroad.

The conference aimed to update the knowledge on managing breast cancer and implementing personalized genetically targeted therapy - clarifying the potential implications of a patient's genomic results and the impact of Precision Medicine on the prevention, diagnosis, and treatment of breast cancer.

Dr. Salha Bujassoum, Senior Medical Oncologist at Hamad Medical Corporation's (HMC) National Center for Cancer Care and Research (NCCCR), said: "Precision Medicine is providing new hope to patients and their families in Qatar. The concept of an individualized approach is not new in the field of breast cancer; however, recent advances in genomic medicine allowed more personalized approaches".

Click on the news' source link to read the full story.